Loading...

Microbot Medical Inc.

MBOTNASDAQ
Healthcare
Medical - Instruments & Supplies
$2.34
$-0.14(-5.65%)

Microbot Medical Inc. (MBOT) Stock Overview

Explore Microbot Medical Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
0.00%
Profit Growth
$-0.53
101.69%
EPS Growth
$-0.53
101.10%
Operating Margin
0.00%
17.96%
ROE
-84.72%
101.69%
Dividend Yield
0.00%

Analyst Recommendations

Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0

Price Targets

Low$0.00
Average$0.00
High$0.00

Company Profile

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

CEO

Mr. Harel Gadot

Employees

20

Headquarters

25 Recreation Park Drive, Hingham, MA

Founded

1992

Frequently Asked Questions